Crispr Therapeutics options imply 7.2% move in share price post-earnings
The Fly

Crispr Therapeutics options imply 7.2% move in share price post-earnings

Pre-earnings options volume in Crispr Therapeutics is normal with puts leading calls 9:8. Implied volatility suggests the market is anticipating a move near 7.2%, or $5.65, after results are released. Median move over the past eight quarters is 7.6%.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on CRSP:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App